Non-Hodgkin lymphoma and obesity: a pooled analysis from the InterLymph Consortium.
about
Risk factors for etiology and prognosis of mantle cell lymphomaCurrent understanding of lifestyle and environmental factors and risk of non-hodgkin lymphoma: an epidemiological updateMedical history, lifestyle, family history, and occupational risk factors for mantle cell lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes ProjectEtiologic heterogeneity among non-Hodgkin lymphoma subtypes: the InterLymph Non-Hodgkin Lymphoma Subtypes ProjectVariation in effects of non-Hodgkin lymphoma risk factors according to the human leukocyte antigen (HLA)-DRB1*01:01 allele and ancestral haplotype 8.1Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium.Smoking, alcohol use, obesity, and overall survival from non-Hodgkin lymphoma: a population-based studyTemporal and demographic patterns of non-Hodgkin's lymphoma incidence in Pennsylvania.Associations between anthropometry, cigarette smoking, alcohol consumption, and non-Hodgkin lymphoma in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening TrialMedical history, lifestyle, family history, and occupational risk factors for lymphoplasmacytic lymphoma/Waldenström's macroglobulinemia: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.Rationale and Design of the International Lymphoma Epidemiology Consortium (InterLymph) Non-Hodgkin Lymphoma Subtypes ProjectMedical history, lifestyle, family history, and occupational risk factors for mycosis fungoides and Sézary syndrome: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.Medical history, lifestyle, family history, and occupational risk factors for diffuse large B-cell lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.InterLymph hierarchical classification of lymphoid neoplasms for epidemiologic research based on the WHO classification (2008): update and future directions.Meat intake and non-Hodgkin lymphoma: a meta-analysis of observational studies.Cytokine polymorphisms in Th1/Th2 pathway genes, body mass index, and risk of non-Hodgkin lymphoma.Design and validity of a clinic-based case-control study on the molecular epidemiology of lymphomaLymphoid malignancies in U.S. Asians: incidence rate differences by birthplace and acculturationRisk factors for non-Hodgkin lymphoma subtypes defined by histology and t(14;18) in a population-based case-control study.Risk Factors of Non-Hodgkin LymphomaObesity and the risk for a hematological malignancy: leukemia, lymphoma, or myelomaNon-Hodgkin Lymphoma, Body Mass Index, and Cytokine Polymorphisms: A Pooled Analysis from the InterLymph Consortium.Epidemiologic overview of malignant lymphoma.New insights into the epidemiology of non-Hodgkin lymphoma and implications for therapyThe association between early life and adult body mass index and physical activity with risk of non-Hodgkin lymphoma: impact of gender.Contributions of Subtypes of Non-Hodgkin Lymphoma to Mortality TrendsPostmenopausal hormone therapy and non-Hodgkin lymphoma: a pooled analysis of InterLymph case-control studiesShort- and Long-term weight changes among United States veterans with diffuse large B-cell lymphoma treated with CHOP chemotherapy.Non-hodgkin lymphoma and circulating markers of inflammation and adiposity in a nested case-control study: the multiethnic cohort.Tumor necrosis factor-308 polymorphism with the risk and prognosis of non-Hodgkin lymphomas: a meta-analysis studyBody size in relation to incidence of subtypes of haematological malignancy in the prospective Million Women Study.Etiologic heterogeneity among non-Hodgkin lymphoma subtypes.A prospective analysis of body size during childhood, adolescence, and adulthood and risk of non-Hodgkin lymphoma.Body size, recreational physical activity, and B-cell non-Hodgkin lymphoma risk among women in the California teachers study.Polymorphisms in DNA repair pathway genes, body mass index, and risk of non-Hodgkin lymphoma.Unraveling the interactions between environmental factors and genetic polymorphisms in non-Hodgkin lymphoma risk.A review of the role of lymphoma markers and occupational and environmental exposures.Body mass index and other anthropometric parameters in patients with diffuse large B-cell lymphoma: physiopathological significance and predictive value in the immunochemotherapy era.To Each Its Own: Linking the Biology and Epidemiology of NHL Subtypes.Incidence and time trends of childhood lymphomas: findings from 14 Southern and Eastern European cancer registries and the Surveillance, Epidemiology and End Results, USA.
P2860
Q26858960-14002AA1-2D4F-4D07-BE17-6DCEFEC8E732Q28388876-AA03250B-76D4-4FC9-B37C-871A6FAF0C81Q28393760-0822ACEF-0FCB-44B6-94EC-501AB128F60EQ28393769-7005D862-7AA1-44AC-82D6-6B3ED0546FB9Q28742972-D72DA362-95EC-4636-A13E-8C92714ED817Q33741481-F0AFD4B7-78E1-43C9-9A42-1E84589ED1FFQ33930843-F101F405-3605-47F1-A2AE-8DE03143CAE6Q33956734-22E109E2-6334-4AED-88E1-51024E0E113EQ34041757-ADADF8EA-8559-48A0-A97B-45A72B8A6AACQ34137888-B1C52E7D-0BC0-4705-BD0C-F09A7C6482F5Q34137915-E1E04262-A8B3-49A4-8D00-FD332ECDA807Q34137936-9F5F593E-CE68-4F1C-B1AC-73893EE9C954Q34137948-D2D68415-9981-4DCD-858A-E1B0EAF418B6Q34360414-77697B89-3B2D-4040-8E6C-07207759238AQ34522070-D2F71139-0570-4ECD-AB35-9B475A0DA6E0Q34542117-A5A0BCCF-35E5-4100-B2B7-E688843F39EAQ35031964-C207B217-16EB-495A-A414-C99AFBCAD89CQ35036813-29065DCA-B36B-4133-BB16-124C4FB875CAQ35074713-DF696A34-CEE5-492C-87C8-F56B0F0631C4Q35499320-6A3F0920-877D-4E46-B56A-53E79FC82529Q35583755-7D76999F-D2B8-4868-B5DA-E7DA05750BD7Q35815614-26E89345-E18E-4CA2-B4BC-AEDDC8448973Q36074055-94E9E202-8441-4978-9A33-D3FC70EE2790Q36424072-C8E78AFE-BCCC-4809-9CF8-F8F9A1ACB7E6Q36443311-53823CA4-1069-4712-A840-F71001C22548Q36463900-33679BE3-E136-4709-BD67-F974A6A5E17BQ36551642-466BC6DB-40EA-4D91-B490-5EB5DDCD4A32Q36576726-5A0E9D14-A6CC-42C3-B064-44AFF91B349BQ36680965-5474344F-7A89-4E35-AD8B-75F75F4779A4Q36729256-B1F7490C-9E97-49A0-8F80-7797C0C62435Q36924751-D453655E-593E-4481-B5A7-54F316E37A01Q37003547-9A88B717-FD80-478B-842B-0215305FEC90Q37144522-03D6FD7A-7D1F-483D-9B61-DE5389182EEFQ37432378-E5C6E25A-7775-42EE-86E0-2B75C6AA6561Q37515655-53A54293-8858-4A8D-95FB-068FC10448E1Q37705418-21B6B14D-3E47-4768-9C25-964433127DCFQ38029093-FD45A072-3A16-4496-82A4-0C4F4B58CC07Q38264354-96B23CD1-04FC-4CDD-943C-299345D25A77Q38536210-891AB169-A606-4C7E-8344-C5C7F655E425Q39273191-C34511B7-65AF-462E-94A5-3098953C6FAC
P2860
Non-Hodgkin lymphoma and obesity: a pooled analysis from the InterLymph Consortium.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Non-Hodgkin lymphoma and obesity: a pooled analysis from the InterLymph Consortium.
@en
Non-Hodgkin lymphoma and obesity: a pooled analysis from the InterLymph Consortium.
@nl
type
label
Non-Hodgkin lymphoma and obesity: a pooled analysis from the InterLymph Consortium.
@en
Non-Hodgkin lymphoma and obesity: a pooled analysis from the InterLymph Consortium.
@nl
prefLabel
Non-Hodgkin lymphoma and obesity: a pooled analysis from the InterLymph Consortium.
@en
Non-Hodgkin lymphoma and obesity: a pooled analysis from the InterLymph Consortium.
@nl
P2093
P2860
P50
P356
P1476
Non-Hodgkin lymphoma and obesity: a pooled analysis from the InterLymph Consortium.
@en
P2093
Brian C-H Chiu
Eleanor V Willett
Elizabeth A Holly
Interlymph Consortium
John J Spinelli
Karin Ekstrom Smedby
Lindsay M Morton
Marc Maynadie
Martine Vornanen
P2860
P304
P356
10.1002/IJC.23344
P50
P577
2008-05-01T00:00:00Z